| Financial Year |
March 31 2023 |
| Monetary Funds |
452,844,040.85 |
| Held-for-trading Financial Assets |
222,803,010.90 |
| Notes Receivable |
-- |
| Accounts Receivable |
492,315,706.85 |
| Advances to Suppliers |
33,883,320.11 |
| Other Receivables |
70,759,682.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,696,870.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,925,595.85 |
| Total Current Assets |
1,504,745,966.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,912,990,572.43 |
| Under-construction Projects |
1,047,660,387.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
415,081,963.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
75,177,530.95 |
| Deferred Income Tax Assets |
142,669,681.48 |
| Other Non-Current Assets |
397,651,922.76 |
| Sub-Total of Non-Current Assets |
5,295,625,449.92 |
| Total Assets |
6,800,371,416.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,358,983.01 |
| Accounts Payable |
460,084,330.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
76,737,054.90 |
| Taxes Payable |
128,966,357.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
93,006,356.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,962,817.68 |
| Other Current Liabilities |
1,255,678.50 |
| Sub-Total of Current Liabilities |
802,149,088.70 |
| Long-term Loans |
560,000,000.00 |
| Bonds Payable |
199,387,533.32 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,747,681.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
827,725,266.30 |
| Total Liabilities |
1,629,874,355.00 |
| Paid-In Capital(Or Share Stock) |
1,333,099,296.00 |
| Capital Surplus |
1,429,278,385.76 |
| Surplus Reserve |
478,075,259.47 |
| LESS:Treasury Stock |
54,999,974.10 |
| Undistributed Profits |
1,985,044,094.29 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,170,497,061.42 |
| Owner's Equity（Stockholder's Equity） |
5,170,497,061.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,800,371,416.42 |
